108552
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
中国西南地区产超广谱β-内酰胺酶肺炎克雷伯菌：血流感染的分子特征及危险因素
Authors Wei Y , Jiang Y, Gu C, Ye C, Guo T, Zeng Z, Liu J
Received 5 May 2025
Accepted for publication 31 August 2025
Published 18 September 2025 Volume 2025:18 Pages 4993—5005
DOI https://doi.org/10.2147/IDR.S447539
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Chi H. Lee
Yueshuai Wei,1– 3 Yuan Jiang,1– 3 Chenghong Gu,4 Caihong Ye,1– 3 Tongtong Guo,1– 3 Zhangrui Zeng,1– 3,* Jinbo Liu1– 3,*
1Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of China; 2Sichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Luzhou, People’s Republic of China; 3Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Luzhou, People’s Republic of China; 4Department of Laboratory Medicine, Zigong Fourth People’s Hospital, Zigong, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhangrui Zeng, Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of China, Email zengzhangrui@swmu.edu.cn Jinbo Liu, Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of China, Email liujb7203@swmu.edu.cn
Purpose: The objective of this study was to investigate the molecular characteristics and risk factors of bloodstream infection (BSI) caused by extended-spectrum beta-lactamase producing Klebsiella pneumoniae (ESBL-Kpn).
Methods: Bacterial species were identified using the matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Bruker Daltonik GmbH, Bremen, Germany), while antimicrobial susceptibilities were assessed using the MicroScan WalkAway 96 Plus system (Siemens, Germany) and the microbroth dilution method. Polymerase chain reaction (PCR) was employed to detect common extended-spectrum beta-lactamase resistance genes (blaSHV, blaTEM, blaCTX-M). Multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), capsular serotyping, and serum resistance tests were utilized to analyze the molecular characteristics among the isolated strains. Additionally, a logistic regression analysis was conducted to identify the risk factors associated with BSI caused by ESBL-Kpn.
Results: A total of 371 Klebsiella pneumoniae (K. pneumoniae) strains were isolated from blood samples collected at the Affiliated Hospital of Southwest Medical University between January 2020 and June 2023, among which 45 were confirmed to produce ESBL. Twenty-eight STs were identified, with ST15 being predominant. Most strains exhibited resistance to multiple antibiotics, with blaCTX-M-15 as the predominant ESBL resistance genes. Nine strains (n=9, 20%) of bacteria exhibited high serum resistance, and 27 strains matched capsular serotypes predominantly K17. Multivariate analysis indicated that transferred patients, prior use of cephalosporin antibiotics, and prolonged hospital stay were independent risk factors for ESBL-Kpn BSI.
Conclusion: BSI caused by ESBL-Kpn exhibit high resistance rates. The newly identified ST6835 and ST6837 indicate the emergence and spread of novel clones in Southwest China, highlighting the imperative for enhanced surveillance of ESBL-producing strains.
Keywords: Klebsiella pneumoniae, bloodstream infection, extended-spectrum beta-lactamase, molecular characteristics, risk factors
1Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of China; 2Sichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Luzhou, People’s Republic of China; 3Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Luzhou, People’s Republic of China; 4Department of Laboratory Medicine, Zigong Fourth People’s Hospital, Zigong, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhangrui Zeng, Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of China, Email zengzhangrui@swmu.edu.cn Jinbo Liu, Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of China, Email liujb7203@swmu.edu.cn
Purpose: The objective of this study was to investigate the molecular characteristics and risk factors of bloodstream infection (BSI) caused by extended-spectrum beta-lactamase producing Klebsiella pneumoniae (ESBL-Kpn).
Methods: Bacterial species were identified using the matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Bruker Daltonik GmbH, Bremen, Germany), while antimicrobial susceptibilities were assessed using the MicroScan WalkAway 96 Plus system (Siemens, Germany) and the microbroth dilution method. Polymerase chain reaction (PCR) was employed to detect common extended-spectrum beta-lactamase resistance genes (blaSHV, blaTEM, blaCTX-M). Multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), capsular serotyping, and serum resistance tests were utilized to analyze the molecular characteristics among the isolated strains. Additionally, a logistic regression analysis was conducted to identify the risk factors associated with BSI caused by ESBL-Kpn.
Results: A total of 371 Klebsiella pneumoniae (K. pneumoniae) strains were isolated from blood samples collected at the Affiliated Hospital of Southwest Medical University between January 2020 and June 2023, among which 45 were confirmed to produce ESBL. Twenty-eight STs were identified, with ST15 being predominant. Most strains exhibited resistance to multiple antibiotics, with blaCTX-M-15 as the predominant ESBL resistance genes. Nine strains (n=9, 20%) of bacteria exhibited high serum resistance, and 27 strains matched capsular serotypes predominantly K17. Multivariate analysis indicated that transferred patients, prior use of cephalosporin antibiotics, and prolonged hospital stay were independent risk factors for ESBL-Kpn BSI.
Conclusion: BSI caused by ESBL-Kpn exhibit high resistance rates. The newly identified ST6835 and ST6837 indicate the emergence and spread of novel clones in Southwest China, highlighting the imperative for enhanced surveillance of ESBL-producing strains.
Keywords: Klebsiella pneumoniae, bloodstream infection, extended-spectrum beta-lactamase, molecular characteristics, risk factors